Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/13/2023 | MIMEDX GROUP, INC. | MDXG | Grant | Common Stock | 35.4k | $4.95 | $175k | | 06/13/2023 |
06/07/2022 | MIMEDX GROUP, INC. | MDXG | Grant | Common Stock | 44.2k | $3.96 | $175k | | 06/07/2022 |
05/27/2021 | MIMEDX GROUP, INC. | MDXG | Grant | Common Stock | 17.1k | $10.26 | $175k | | 05/27/2021 |
05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 6k | $0.00 | $0 | | 05/14/2020 |
05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 12k | $19.40 | $232.8k | | 05/14/2020 |
05/09/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 9k | $12.82 | $115.4k | | 05/09/2019 |
05/09/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 4.5k | $0.00 | $0 | | 05/09/2019 |
02/08/2019 | CohBar, Inc. | CWBR | Grant | Stock Options (right to buy) | 200k | $3.15 | $630k | | 02/08/2019 |
11/27/2018 | Corium International, Inc. | CORI | Disposition | Common Stock | 34.2k | $12.50 | $427.5k | | 11/27/2018 |
11/27/2018 | Corium International, Inc. | CORI | Disposition | Director Stock Option (Right to Buy) | 7.9k | $4.14 | $32.8k | | 11/27/2018 |
11/27/2018 | Corium International, Inc. | CORI | Disposition | Director Stock Option (Right to Buy) | 12k | $5.79 | $69.5k | | 11/27/2018 |
11/27/2018 | Corium International, Inc. | CORI | Disposition | Director Stock Option (Right to Buy) | 12k | $7.19 | $86.3k | | 11/27/2018 |
11/27/2018 | Corium International, Inc. | CORI | Disposition | Director Stock Option (Right to Buy) | 15k | $4.59 | $68.8k | | 11/27/2018 |
11/27/2018 | Corium International, Inc. | CORI | Disposition | Director Stock Option (Right to Buy) | 15k | $11.59 | $173.8k | | 11/27/2018 |
05/10/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 3k | $0.00 | $0 | | 05/10/2018 |
05/10/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 6k | $29.15 | $174.9k | | 05/10/2018 |
03/16/2018 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 5.3k | $31.51 | $168k | | 03/16/2018 |
03/16/2018 | Revance Therapeutics, Inc. | RVNC | Exercise | Common Stock | 4k | $2.55 | $10.2k | | 03/16/2018 |
03/16/2018 | Revance Therapeutics, Inc. | RVNC | Exercise | Common Stock | 1.3k | $2.55 | $3.4k | | 03/16/2018 |
12/01/2017 | Corium International, Inc. | CORI | Grant | Director Stock Option (Right to Buy) | 15k | $11.59 | $173.8k | | 12/01/2017 |
08/21/2017 | Corium International, Inc. | CORI | Exercise | Director Stock Option (Right to Buy) | 33.1k | $2.12 | $70.1k | | 08/21/2017 |